[en] [en] INTRODUCTION: Lichen sclerosus (LS) is an inflammatory skin disease affecting all ages. LS typically involves the anogenital site where it causes itching and soreness. It may lead to sexual and urinary dysfunction in females and males; however, it may be asymptomatic. First signs of LS are redness and oedema, typically followed by whitening of the genital skin; sometimes fissuring, scarring, shrinkage and fusion of structures may follow in its course. LS is associated with an increased risk of genital cancer. LS has a huge impact on the quality of life of affected patients, and it is important to raise more awareness of this not uncommon disease in order to diagnose and treat it early.
OBJECTIVES: The guideline intends to provide guidance on the diagnostic of LS, highlight important aspects in the care of LS patients (part 1), generate recommendations and treatment algorithms (part 2) on topical, interventional and surgical therapy, based on the latest evidence, provide guidance in the management of LS patients during pregnancy, provide guidance for the follow-up of patients with LS and inform about new developments and potential research aspects.
MATERIALS AND METHODS: The guideline was developed in accordance with the EuroGuiDerm Methods Manual v1.3 https://www.edf.one/de/home/Guidelines/EDF-EuroGuiDerm.html. The wording of the recommendations was standardized (as suggested by the GRADE Working Group). The guideline development group is comprised of 34 experts from 16 countries, including 5 patient representatives.
RESULTS: Ultrapotent or potent topical corticosteroids in females and males, adults and children remain gold standard of care for genital LS; co-treatment with emollients is recommended. If standard treatment fails in males, a surgical intervention is recommended, complete circumcision may cure LS in males. UV light treatment is recommended for extragenital LS; however, there is limited scientific evidence. Topical calcineurin inhibitors are second line treatment. Laser treatment, using various wave lengths, is under investigation, and it can currently not be recommended for the treatment of LS. Treatment with biologics is only reported in single cases.
CONCLUSIONS: LS has to be diagnosed and treated as early as possible in order to minimize sequelae like scarring and cancer development. Topical potent and ultrapotent corticosteroids are the gold standard of care; genital LS is often a lifelong disease and needs to be treated long-term.
Disciplines :
Dermatology
Author, co-author :
Kirtschig, G ; Medbase Health Centre, Frauenfeld, Switzerland
Kinberger, M ; Department of Dermatology, Venereology and Allergology, Division of Evidence- Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Kreuter, A; Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, Oberhausen, Germany
Simpson, R; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK
Günthert, A; Gynäkologisches Tumorzentrum St. Anna, Lucerne, Switzerland
van Hees, C; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands
Becker, K; Office for Paediatric Surgery, Bonn, Germany
Ramakers, M J; CenSeRe (Centre for Psychological, Relational, Sexual Health), Voorschoten, The Netherlands
Corazza, M; Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
Müller, S; Department of Dermatology, University Hospital Basel, Basel, Switzerland
von Seitzberg, S; The Danish Lichen Sclerosus Association, Hørve, Denmark
Boffa, M J; Department of Dermatology, Mater Dei Hospital, Msida, Malta
Stein, R; Center for Pediatric, Adolescent and Reconstructive Urology, Medical Faculty Mannheim, University of Medical Center Mannheim, Heidelberg University, Mannheim, Germany
Barbagli, G; Centro Chirurgico Toscano, Arezzo, Italy
Chi, C C ; Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan ; College of Medicine, Chang Gung University, Taoyuan, Taiwan
Dauendorffer, J N ; Department of Dermatology, Centre for Genital and Sexually Transmitted Diseases, University Hospital Saint Louis, Paris, France
Gaskins, M; Department of Dermatology, Venereology and Allergology, Division of Evidence- Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Hiltunen-Back, E; Department of Dermatovenereology, Helsinki University Hospital, Helsinki, Finland
Köllmann, N H; The Swiss Lichen Sclerosus Association, Switzerland/Verein Lichen Sclerosus e.V., Dottikon, Switzerland
Kühn, H; The German Lichen Sclerosus Association, Germany
Larsen, H K; Department of Dermatology and Venereology, Copenhagen University Hospital, Bispebjerg Hospital, Copenhagen, Denmark
Lazzeri, M; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy
Mendling, W; German Center for Infections in Gynecology and Obstetrics, at Helios University Hospital Wuppertal- University Witten/Herdecke, Wuppertal, Germany
Nikkels, Arjen ; Université de Liège - ULiège > Département des sciences cliniques > Dermatologie
Promm, M; Department of Paediatric Urology and Clinic St. Hedwig, University Medical Centre of Regensburg, Regensburg, Germany
Rall, K K; Department of Women's Health, Women's University Hospital Tuebingen, Tuebingen, Germany
Regauer, S; Diagnostic and Research Institute of Pathology, Medical University Graz, Graz, Austria
Sárdy, M ; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary
Sepp, N; Department of Dermatology and Venereology, Ordensklinikum Linz Elisabethinen, Linz, Austria
Thune, T; Department of Dermatology, Haukeland University Hospital, Bergen, Norway
Tsiogka, A ; National and Kapodistrian University of Athens, Faculty of Medicine, 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, Athens, Greece
Vassileva, S; Department of Dermatology and Venereology, University Hospital "Alexandrovska", Medical University - Sofia, Sofia, Bulgaria
Voswinkel, L; The German Lichen Sclerosus Association, Germany
Wölber, L; Department of Gynaecology, University Medical Centre Hamburg-Eppendorf and Centre for Colposcopy and Vulvovaginal Disease Jersualem Hospital Hamburg, Hamburg, Germany
Werner, R N ; Department of Dermatology, Venereology and Allergology, Division of Evidence- Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
This EuroGuiDerm guideline was funded through the EuroGuiDerm Centre for Guideline Development. The European Dermatology Forum is responsible for fundraising and holds all raised funds in one account. The EuroGuiDerm Team is not involved in fundraising or in the decision\u2010making on which guideline (GL) or consensus statement (CS) development is funded. The decisions on which GL/CS is funded are made by the EuroGuiDerm Board of Directors independently. The EDF or any other body supporting the EuroGuiDerm is never involved in the guideline development and had no say on the content or focus of the guideline.
Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group; 2013. https://gdt.gradepro.org/app/handbook/handbook.html
Kirtschig G, Becker K, Günthert A, Jasaitiene D, Cooper S, Chi CC, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29:e1–e43.
Green C, Guest J, Ngu W. Long-term follow-up of women with genital lichen sclerosus. Menopause Int. 2013;19:28–29.
Balasubramaniam P, Lewis FM. Long-term follow-up of patients with lichen sclerosus: does it really happen? J Obstet Gynaecol. 2007;27:282.
Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol. 2004;140:702–706.
Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777–1783.
Arnold S, Fernando S, Rees S. Living with vulval lichen sclerosus: a qualitative interview study. Br J Dermatol. 2022;187:909–918.
Ranum A, Pearson DR. The impact of genital lichen sclerosus and lichen planus on quality of life: a review. Int J Womens Dermatol. 2022;8:e042.
Directorate-General for Research and Innovation (European Commission) et al. Scoping study on evidence to tackle high-burden under-researched medical conditions: discussion paper. Publications Office of the European Union; 2023. https://op.europa.eu/en/publication-detail/-/publication/eae32303-96e3-11ed-b508-01aa75ed71a1/language-en/format-PDF/source-278963958
Neill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163:672–682.
Niamh L, Naveen S, Hazel B. Diagnosis of vulval inflammatory dermatoses: a pathological study with clinical correlation. Int J Gynecol Pathol. 2009;28:554–558.
Kirtschig G, Cooper S. Gynecologic dermatology: symptoms, signs and clinical management. London: JP Medical Ltd; 2016.
Fung MA, LeBoit PE. Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus. Am J Surg Pathol. 1998;22:473–478.
Day T, Wilkinson E, Rowan D, Scurry J. Clinicopathologic diagnostic criteria for vulvar lichen planus. J Low Genit Tract Dis. 2020;24:317–329.
Attili VR, Attili SK. Clinical and histopathological spectrum of genital lichen sclerosus in 133 cases: focus on the diagnosis of pre-sclerotic disease. Indian J Dermatol Venereol Leprol. 2022;88:774–780.
Kirtschig G, Happle R. Lichen sclerosus et atrophicus of the vulva. Successful local treatment with a potent corticosteroid [Lichen sclerosus et atrophicus der Vulva. Erfolgreiche Lokalbehandlung mit einem potenten Kortikosteroid]. Gynakologe. 1994;27:181–182.
Derrick EK, Ridley CM, Kobza-Black A, McKee PH, Neill SM. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol. 2000;143:1217–1223.
Sahn EE, Bluestein EL, Oliva S. Familial lichen sclerosus et atrophicus in childhood. Pediatr Dermatol. 1994;11:160–163.
Aslanian FM, Marques MT, Matos HJ, Pontes LFS, Porto LCS, Azevedo LMS, et al. HLA markers in familial lichen sclerosus. J Dtsch Dermatol Ges. 2006;4:842–847.
Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24:1031–1034.
Higgins CA, Cruickshank ME. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus. J Obstet Gynaecol. 2012;32:271–275.
Virgili A, Borghi A, Cazzaniga S, di Landro A, Naldi L, Minghetti S, et al. New insights into potential risk factors and associations in genital lichen sclerosus: data from a multicentre Italian study on 729 consecutive cases. J Eur Acad Dermatol Venereol. 2017;31:699–704.
Kirtschig G, Kuik D. A Dutch cohort study confirms familial occurrence of anogenital lichen sclerosus. J Womens Health Care. 2014;3:209–211.
Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132:197–203.
Gao XH, Barnardo MC, Winsey S, Ahmad T, Cook J, Agudelo JD, et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005;125:895–899.
Azurdia RM, Luzzi GA, Byren I, Welsh K, Wojnarowska F, Marren P, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol. 1999;140:79–83.
Khan Mohammad BP. The Immunogenetics of Morphea and lichen sclerosus. Adv Exp Med Biol. 2022;1367:155–172.
Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000;142:481–484.
Villa M, Dragonetti E, Grande M, Bove P, Sansalone S, Rulli F, et al. Skin phototype and local trauma in the onset of balanitis xerotica obliterans (BXO) in circumcised patients. In Vivo. 2012;26(1):143–146.
Koupaie J. Letter: lichen sclerous et atrophicus associated with turner syndrome. Arch Dermatol. 1976;112:1174.
Lagerstedt M, Karvinen K, Joki-Erkkilä M, Huotari-Orava R, Snellman E, Laasanen SL. Childhood lichen sclerosus–a challenge for clinicians. Pediatr Dermatol. 2013;30:444–450.
Wegiel M, Antosz A, Gieburowska J, Szeliga K, Hankus M, Grzybowska-Chlebowczyk U, et al. Autoimmunity predisposition in girls with turner syndrome. Front Endocrinol (Lausanne). 2019;10:511.
Edmonds E, Barton G, Buisson S, Francis N, Gotch F, Game L, et al. Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol. 2011;92:320–325.
Gambichler T, Skrygan M, Czempiel V, Tigges C, Kobus S, Meier JJ, et al. Differential expression of connective tissue growth factor and extracellular matrix proteins in lichen sclerosus. J Eur Acad Dermatol Venereol. 2012;26:207–212.
Gambichler T, Terras S, Kreuter A, Skrygan M. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus: further support for epigenetic mechanisms. Br J Dermatol. 2014;170:687–693.
Rotondo JC, Borghi A, Selvatici R, Magri E, Bianchini E, Montinari E, et al. Hypermethylation-induced inactivation of the IRF6 gene as a possible early event in progression of vulvar squamous cell carcinoma associated with lichen Sclerosus. JAMA Dermatol. 2016;152:928–933.
Rotondo JC, Borghi A, Selvatici R, Mazzoni E, Bononi I, Corazza M, et al. Association of Retinoic Acid Receptor β gene with onset and progression of lichen Sclerosus-associated vulvar squamous cell carcinoma. JAMA Dermatol. 2018;154:819–823.
Terlou A, Santegoets LA, van der Meijden WI, Heijmans-Antonissen C, Swagemakers SMA, van der Spek PJ, et al. An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155. J Invest Dermatol. 2012;132:658–666.
Pilatz A, Altinkilic B, Schormann E, Maegel L, Izykowski N, Becker J, et al. Congenital phimosis in patients with and without lichen sclerosus: distinct expression patterns of tissue remodeling associated genes. J Urol. 2013;189:268–274.
Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 1997;11:996–1007.
Kaya G, Augsburger E, Stamenkovic I, Saurat JH. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J Invest Dermatol. 2000;115:1054–1058.
Farrell AM, Marren P, Dean D, Wojnarowska F. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol. 1999;140:1087–1092.
Tchórzewski H, Rotsztejn H, Banasik M, Lewkowicz P, Głowacka E. The involvement of immunoregulatory T cells in the pathogenesis of lichen sclerosus. Med Sci Monit. 2005;11:Cr39–Cr43.
Corazza M, Oton-Gonzalez L, Scuderi V, Rotondo JC, Lanzillotti C, di Mauro G, et al. Tissue cytokine/chemokine profile in vulvar lichen sclerosus: an observational study on keratinocyte and fibroblast cultures. J Dermatol Sci. 2020;100:223–226.
Zhao Y, Zhao S, Li H, Qin X, Wu X. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts. Oncol Lett. 2018;16:2559–2564.
Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362:118–123.
Edmonds EV, Oyama N, Chan I, Francis N, McGrath JA, Bunker CB. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol. 2011;165:218–219.
Howard A, Dean D, Cooper S, Kirtshig G, Wojnarowska F. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol. 2004;45:12–15.
Baldo M, Bhogal B, Groves RW, Powell J, Wojnarowska F. Childhood vulval lichen sclerosus: autoimmunity to the basement membrane zone protein BP180 and its relationship to autoimmunity. Clin Exp Dermatol. 2010;35:543–545.
Baldo M, Bailey A, Bhogal B, Groves RW, Ogg G, Wojnarowska F. T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus. J Eur Acad Dermatol Venereol. 2010;24:186–190.
Patsatsi A, Kyriakou A, Mantas A, Vavilis D, Patsialas C, Sotiriadis D. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with disease activity and pruritus. Acta Derm Venereol. 2014;94:711–712.
Sander CS, Ali I, Dean D, Thiele JJ, Wojnarowska F. Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br J Dermatol. 2004;151:627–635.
Grassi S, Tadiotto Cicogna G, Magri F, Caterina Fortuna M, Caro G, Pernazza A, et al. Frontal fibrosing alopecia and genital lichen sclerosus: single-center experience. J Cosmet Dermatol. 2021;20:615–620.
Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol. 1981;104:563–566.
Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity–a study of 350 women. Br J Dermatol. 1988;118:41–46.
McGrath EJ, Davies MG. Lichen sclerosus arising from a chronic wound and coexistent with multiple sclerosis. J Eur Acad Dermatol Venereol. 2005;19:139–141.
Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008;144:1432–1435.
Bjekić M, Šipetić S, Marinković J. Risk factors for genital lichen sclerosus in men. Br J Dermatol. 2011;164:325–329.
Kreuter A, Wischnewski J, Terras S, Altmeyer P, Stücker M, Gambichler T. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol. 2012;67:1157–1162.
Kreuter A, Kryvosheyeva Y, Terras S, Moritz R, Möllenhoff K, Altmeyer P, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93:238–241.
Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151:1061–1067.
Hu J, Hesson A, Haefner HK, Rominski S. The prevalence of self-reported medical comorbidities in patients with vulvar lichen sclerosus: a single-center retrospective study. Int J Gynaecol Obstet. 2021;153:340–343.
Kette B, Ringel N, Bradley S, Buck E, Tefera E, Iglesia C. Prevalence of lichen sclerosus in patients with autoimmune connective tissue disorders and pelvic floor disorders: a retrospective cohort study. Proceedings of the 44th AUGS/IUGA annual meeting, Nashville, USA. Int Urogynecol. 2019; 307–8.
Guarneri F, Giuffrida R, Di Bari F, Cannavò SP, Benvenga S. Thyroid autoimmunity and lichen. Front Endocrinol (Lausanne). 2017;8:146.
Simpkin S, Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis. Australas J Dermatol. 2007;48:28–31.
Eberz B, Berghold A, Regauer S. High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women. Obstet Gynecol. 2008;111:1143–1147.
Becker K, Meissner V, Farwick W, Bauer R, Gaiser MR. Lichen sclerosus and atopy in boys: coincidence or correlation? Br J Dermatol. 2013;168:362–366.
Elakis JA, Hall AP. Skin disease of penis and male genitalia is linked to atopy and circumcision: caseload in a male genital dermatology clinic. Australas J Dermatol. 2017;58:e68–e72.
Kirk PS, Yi Y, Hadj-Moussa M, Malaeb BS. Diversity of patient profile, urethral stricture, and other disease manifestations in a cohort of adult men with lichen sclerosus. Investig Clin Urol. 2016;57:202–207.
Hofer MD, Meeks JJ, Mehdiratta N, Granieri MA, Cashy J, Gonzalez CM. Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking. World J Urol. 2014;32:105–108.
Kalra S, Chawla A. Diabetes and balanoposthitis. J Pak Med Assoc. 2016;66:1039–1041.
Fan R, Leasure AC, Maisha FI, Cohen JM, Little AJ. Thyroid disorders associated with lichen sclerosus: a case-control study in the all of us research program. Br J Dermatol. 2022;187:797–799.
Berger MB, Damico NJ, Menees SB, Fenner DE, Haefner HK. Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract Dis. 2012;16:285–289.
Hieta N, Kurki S, Rintala M, Söderlund J, Hietanen S, Orte K. Association of vulvar melanoma with lichen sclerosus. Acta Derm Venereol. 2019;99:339–340.
la Spina M, Meli MC, de Pasquale R, Perrotta RE, Lanzafame S, Caltabiano R, et al. Vulvar melanoma associated with lichen sclerosus in a child: case report and literature review. Pediatr Dermatol. 2016;33:e190–e194.
Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50:477–480.
Kirtschig G. Lichen sclerosus-presentation, diagnosis and management. Dtsch Arztebl Int. 2016;113:337–343.
West DS, Papalas JA, Selim MA, Vollmer RT. Dermatopathology of the foreskin: an institutional experience of over 400 cases. J Cutan Pathol. 2013;40:11–18.
Tasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol. 2003;28:128–133.
Leibovitz A, Kaplun VV, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr. 2000;31:1–4.
Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971;57:9–30.
Clayton R, Stewart E, Wojnarowska F. Rising demand for the services of a dedicated dermatological vulval clinic without changes in disease profile. Proceedings of the 15th Congress of the European Academy of Dermatology and Venereology. 2006.
Halonen P, Jakobsson M, Heikinheimo O, Gissler M, Pukkala E. Incidence of lichen sclerosus and subsequent causes of death: a nationwide Finnish register study. BJOG. 2020;127:814–819.
Kizer WS, Prarie T, Morey AF. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med J. 2003;96:9–11.
Halonen P, Jakobsson M, Heikinheimo O, Riska A, Gissler M, Pukkala E. Lichen sclerosus and risk of cancer. Int J Cancer. 2017;140:1998–2002.
McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol Ther. 2010;23:523–532.
Edmonds EV, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26:730–737.
Meuli M, Briner J, Hanimann B, Sacher P. Lichen sclerosus et atrophicus causing phimosis in boys: a prospective study with 5-year followup after complete circumcision. J Urol. 1994;152:987–989.
Becker K. Lichen sclerosus in boys. Dtsch Arztebl Int. 2011;108:53–58.
Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32:393–416; quiz 7–8.
Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J. 2012;59:A4424.
Kyriakis KP, Emmanuelides S, Terzoudi S, Palamaras I, Damoulaki E, Evangelou G. Gender and age prevalence distributions of morphea en plaque and anogenital lichen sclerosus. J Eur Acad Dermatol Venereol. 2007;21:825–826.
García-Bravo B, Sánchez-Pedreño P, Rodríguez-Pichardo A, Camacho F. Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes. J Am Acad Dermatol. 1988;19:482–485.
Steigleder G, Schlüter M. Lichen sclerosus et atrophicus. In: Andrade R, Gumport SL, Popkin GL, Rees TD, editors. Cancer of the skin. Philadelphia, London, Toronto: Saunders; 1976.
Krapf JM, Smith AB, Cigna ST, Goldstein AT. Presenting symptoms and diagnosis of vulvar lichen Sclerosus in premenopausal women: a cross-sectional study. J Low Genit Tract Dis. 2022;26:271–275.
Ledwig PA, Weigand DA. Late circumcision and lichen sclerosus et atrophicus of the penis. J Am Acad Dermatol. 1989;20:211–214.
Marren P, De Berker D, Millard P, Wojnarowska F. Bullous and haemorrhagic lichen sclerosus with scalp involvement. Clin Exp Dermatol. 1992;17:354–356.
Basak PY, Basak K. Lichen sclerosus et atrophicus of the scalp: satisfactory response to acitretin. J Eur Acad Dermatol Venereol. 2002;16:183–185.
Schulten EA, Starink TM, van der Waal I. Lichen sclerosus et atrophicus involving the oral mucosa: report of two cases. J Oral Pathol Med. 1993;22:374–377.
Tremaine RD, Miller RA. Lichen sclerosus et atrophicus. Int J Dermatol. 1989;28:10–16.
Ramrakha-Jones VS, Paul M, McHenry P, Burden AD. Nail dystrophy due to lichen sclerosus? Clin Exp Dermatol. 2001;26:507–509.
Zendell K, Edwards L. Lichen sclerosus with vaginal involvement: report of 2 cases and review of the literature. JAMA Dermatol. 2013;149:1199–1202.
Bhargava K, Lewis FM. Lichen sclerosus occurring on vaginal mucosa secondary to uterine prolapse. J Obstet Gynaecol. 2013;33:319–320.
Shasi PB, Chapman HT, Evans DT, Jaleel H. Psychological and psychiatric morbidity in lichen sclerosus in a cohort recruited from a genitourinary medicine clinic. Int J STD AIDS. 2010;21:17–18.
Parygina G, Slusarenko A, Smirnova I. Mental disorder in females with chronic vulvar dermatoses – the structure and risk factors. Proceedings of the 24th World congress of Dermatology, Milan. 2019.
Baykal C, Kobaner GB, Copur S, Buyukbabani N. Lichen sclerosus on the sites of striae distensae and a surgical scar in a patient with coexistent morphea. Acta Dermatovenerol Croat. 2019;27:44–46.
Warrington SA, de San Lazaro C. Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child. 1996;75:512–516.
Powell J, Wojnarowska F. Childhood vulval lichen sclerosus and sexual abuse are not mutually exclusive diagnoses. BMJ. 2000;320:311.
Sideri M, Parazzini F, Rognoni MT, la Vecchia C, Negri E, Garsia S, et al. Risk factors for vulvar lichen sclerosus. Am J Obstet Gynecol. 1989;161:38–42.
Tang GX, Wu X, Chen JP, Zhou BS. Study on the risk factors of 100 cases with vulvar dystrophy. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi [Chinese]. 2003;24(10):932–934.
Edwards LR, Privette ED, Patterson JW, Tchernev G, Chokoeva AA, Wollina U, et al. Radiation-induced lichen sclerosus of the vulva: first report in the medical literature. Wien Med Wochenschr. 2017;167:74–77.
Moftah N. Radiotherapy related dermatoses. Journal of the Dermatology Nurses' Association Conference: 24th World Congress of Dermatology Milan Italy. 2020;12:85–88.
Gupta S, Malhotra AK, Ajith C. Lichen sclerosus: role of occlusion of the genital skin in the pathogenesis. Indian J Dermatol Venereol Leprol. 2010;76:56–58.
Owen CM, Yell JA. Genital lichen sclerosus associated with incontinence. J Obstet Gynaecol. 2002;22:209–210.
Edmonds EV, Bunker CB. Nuclear magnetic resonance spectroscopy of urine in male genital lichen sclerosus. Br J Dermatol. 2010;163:1355–1356.
Bunker CB. Occlusion, urine and genital lichen sclerosus. Indian J Dermatol Venereol Leprol. 2012;78:367–368.
Bratila E, Cirstoiu M, Mehedintu C, Berceanu C, Bohiltea R, Toader O, et al. The effect of chronic vulvar dystrophy on urinary continence in patients at climacterium. Maturitas. 2017;100:169.
Kravvas G, Muneer A, Watchorn R, Castiglione F, Haider A, Freeman A, et al. Male genital lichen sclerosus, micro incontinence and occlusion: mapping the disease across the prepuce. Clin Exp Dermatol. 2022;12:12.
Panou E, Panagou E, Foley C, Kravvas G, Watchorn R, Alnajjar H, et al. Male genital lichen sclerosus associated with urological interventions and microincontinence: a case series of 21 patients. Clin Exp Dermatol. 2022;47:107–109.
Becker K. Atopy, the barrier, urine and genital lichen sclerosus: reply from the authors. Br J Dermatol. 2013;169:953–954.
Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol. 2008;144:591–598.
Aberer E, Surtov-Pudar M, Wilfinger D, Deutsch A, Leitinger G, Schaider H. Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Arch Dermatol Res. 2018;310:117–126.
Vasudevan B, Sagar A, Bahal A, Mohanty AP. Extragenital lichen sclerosus with aetiological link to Borrelia. Med J Armed Forces India. 2011;67:370–373.
Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. Int J Dermatol. 2006;45:1104–1106.
Zollinger T, Mertz KD, Schmid M, Schmitt A, Pfaltz M, Kempf W. Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature. J Cutan Pathol. 2010;37:571–577.
Ozkan S, Atabey N, Fetil E, Erkizan V, Gunes AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol. 2000;39:278–283.
Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumburg-Lever G, Lange R, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol. 1997;133:41–44.
Afa G, Caprilli F, Crescimbeni E, Morrone A, Prignano G, Fazio M. Anti-Borrelia burgdorferi antibodies in chronic erythema migrans, benign lymphadenosis cutis, scleroderma and scleroatrophic lichen [Anticorpi anti-Borrelia burgdorferi nell'eritema cronico migrante, nella lymphadenosis cutis benigna, nella sclerodermia e nel lichen scleroatrofico]. G Ital Dermatol Venereol. 1990;125:369–373.
Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol. 1997;77:299–304.
Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100:717–720.
Müller KE. Damage of collagen and elastic fibres by borrelia burgdorferi – known and new clinical and histopathological aspects. Open Neurol J. 2012;6:179–186.
DeVito JR, Merogi AJ, Vo T, Boh EE, Fung HK, Freeman SM, et al. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol. 1996;23:350–358.
Colomé-Grimmer MI, Payne DA, Tyring SK, Sánchez RL. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States. Arch Dermatol. 1997;133:1174.
Vasudevan B, Chatterjee M. Lyme borreliosis and skin. Indian J Dermatol. 2013;58:167–174.
Aberer E, Schmidt BL, Breier F, Kinaciyan T, Luger A. Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus [3]. Arch Dermatol. 1999;135(2):210–212.
Aberer E, Kollegger H, Kristoferitsch W, Stanek G. Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol. 1988;19:820–825.
Menni S, Pistritto G, Gianni E. Infantile sclero-atrophic lichen and infection caused by Borrelia burgdorferi [Lichen sclero-atrofico infantile e infezione da Borrelia burgdorferi]. G Ital Dermatol Venereol. 1989;124:267–269.
Svecova D, Buchvald J. Borrelia burgdorferi antibodies in scleroderma circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma annulare, erythema annulare and chronic urticaria [Protilátky proti Borrelia burgdorferi pri sclerodermia circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma anulare, erythema anulare a urticaria chronica]. Bratisl Lek Listy. 2000;101:194–199.
George AA, Hixson CD, Peckham SJ, Tyler D, Zelger B. A case of oral lichen sclerosus with gingival involvement and Borrelia identification. Histopathology. 2014;65:146–148.
Fesler MC, Middelveen MJ, Burke JM, Stricker RB. Erosive vulvovaginitis associated with Borrelia burgdorferi infection. J Investig Med High Impact Case Rep. 2019;7:2324709619842901.
Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–1148.
Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol. 1990;12:357–362.
Breier F, Khanakah G, Stanek G, Kunz G, Aberer E, Schmidt B, et al. Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol. 2001;144:387–392.
Edmonds E, Mavin S, Francis N, Ho-Yen D, Bunker C. Borrelia burgdorferi is not associated with genital lichen sclerosus in men. Br J Dermatol. 2009;160:459–460.
Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol. 1987;9:374–379.
Pinazo Canales I, Betlloch Mas I, Mestre Bauza F, Salva Armengod F, Parras Vázquez F, Alomar CJ. Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans [Determinación de anticuerpos frente a Borrelia burgdorferi en pacientes con morfea, liquen escleroso y atrófico y eritema crónico migrans]. Rev Clin Esp. 1990;186:320–323.
Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol. 1995;33:617–620.
Tuffanelli D. Do some patients with morphea and lichen sclerosis et atrophicans have a Borrelia infection? Am J Dermatopathol. 1987;9(5):371–373.
Aberer E, Neumann R, Lubec G. Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms. Acta Derm Venereol. 1987;67:62–65.
Kaya G, Berset M, Prins C, Chavaz P, Saurat JH. Chronic borreliosis presenting with morphea- and lichen sclerosus et atrophicus-like cutaneous lesions. A case report. Dermatology. 2001;202:373–375.
Buechner SA, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic, and immunohistochemical observations. J Am Acad Dermatol. 1993;29:190–196.
Asbrink E. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Acta Derm Venereol Suppl (Stockh). 1985;118:1–63.
Katinka P, Dora P, Antal B, Merksz M, Attila K, Mazán M, et al. In situ mycoplasma infection as aetiological factor in genital lichen sclerosus. J Invest Dermatol. 2010;2:S14.
Ponyai K, Bognar P, Pinter D, Mazan M, Szathmary Z, Ostorhazi E, et al. Mycoplasma infection – a possible etiological cofactor in morphoea and lichen sclerosus et atrophicus. J Invest Dermatol. 2009;2:S102.
Nasca MR, Lacarrubba F, Micali G. Human papillomavirus infection and lichen sclerosus: coincidence or link? Int J Dermatol. 2018;57:617–618.
Shim TN, Harwood CA, Marsh SG, Gotch FM, Quint W, de Koning MN, et al. Immunogenetics and human papillomavirus (HPV) in male genital lichen sclerosus (MGLSc). Int J STD AIDS. 2020;31:1334–1339.
Pilatz A, Altinkilic B, Rusz A, Izykowski N, Traenkenschuh W, Rische J, et al. Role of human papillomaviruses in persistent and glucocorticoid-resistant juvenile phimosis. J Eur Acad Dermatol Venereol. 2013;27:716–721.
Huang HJ, Murakami T, Yamabe T. Papillomavirus infection of the vulva. Nippon Sanka Fujinka Gakkai Zasshi – Acta Obstetrica et Gynaecologica Japonica. 1987;39:959–964.
Aide S, Lattario FR, Almeida G, do Val IC, da Costa Carvalho M. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus. J Low Genit Tract Dis. 2010;14:319–322.
Lacour J, Nicot T, Bedane C, Ortonne JP, Bonnetblanc JM. Bullous lichen sclerosus with chronic hepatitis C virus infection [7]. Br J Dermatol. 1997;137(3):474–476.
Basile S, Pinelli S, Benedetti Panici P, Angioli R, Plotti F, Giannarelli D, et al. Association between helicobacter pylori infection and vulvar lichen sclerosus: a clinical comparative study. Eur J Dermatol. 2018;28:226–227.
Brunner A, Medvecz M, Makra N, Sárdy M, Komka K, Gugolya M, et al. Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus. Sci Rep. 2021;11:15999.
Cohen AJ, Gaither TW, Srirangapatanam S, Castellanos ER, Enriquez A, Fergus KB, et al. Synchronous genitourinary lichen sclerosus signals a distinct urinary microbiome profile in men with urethral stricture disease. World J Urol. 2021;39:605–611.
Watchorn RE, van den Munckhof EHA, Quint KD, Eliahoo J, de Koning MNC, Quint WGV, et al. Balanopreputial sac and urine microbiota in patients with male genital lichen sclerosus. Int J Dermatol. 2021;60:201–207.
Chattopadhyay M, Sterling J. Skin diseases affecting the vulva. Obstet Gynaecol Reprod Med. 2011;21(6):169–175.
Liu X, Zhuo Y, Zhou Y, Hu J, Wen H, Xiao C. Analysis of the vulvar skin microbiota in asymptomatic women and patients with vulvar lichen sclerosus based on 16S rRNA sequencing. Front Cell Dev Biol. 2022;10:842031.
Vieira-Baptista P, Cavaco-Gomes J, Lima-Silva J, Beires J, Martinez-de-Oliveira J. What differentiates symptomatic from asymptomatic women with vulvar lichen sclerosus? J Low Genit Tract Dis. 2013;2:S113.
Grasso F, Grasso V. Anxiety as risk factor for vulvar lichen sclerosus et atrophicus. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2014;173(5):317–319.
Wong YW, Powell J, Oxon MA. Lichen sclerosus. A review. Minerva Med. 2002;93:95–99.
Iannaccone AM, Verrusio G, Iurassich S. Female lichen sclerosus genitalis: discomfort and adaptation. Clin Ter. 2016;167:113–120.
Günthert AR, Faber M, Knappe G, Hellriegel S, Emons G. Early onset vulvar lichen Sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137:56–60.
Amri M, Zili J, Belhadjmohamed W, et al. Lichen sclerosus – Monomelic scleroderma association in a diabetic patient. [French]. Association lichen sclereux-sclerodermie monomelique chez une diabetique. Nouvelles Dermatologiques. 2001;20(6):375–378.
Mirastschijski U, Schwenke C, Melchior S, Cedidi C. Buried penis: a comprehensive review on Aetiology, classification and plastic-surgical reconstruction [Buried Penis: Aktuelle Ubersicht uber Atiologie, Klassifikation und plastisch-chirurgische Rekonstruktion]. Handchir Mikrochir Plast Chir. 2017;49:78–84.
Anandan L, Mohammed A. Surgical management of buried penis in adults. Cent European J Urol. 2018;71(3):346–352.
Cocci A, Cito G, Falcone M, Capece M, di Maida F, Morelli G, et al. Subjective and objective results in surgical correction of adult acquired buried penis: a single-centre observational study. Arch Ital Urol Androl. 2019;91:25–29.
Falcone M, Capogrosso P, Sokolakis I, Dimitropoulos K, Minhas S, Salonia A, et al. What are the benefits and harms of the surgical management options for adult buried penis? A systematic review. Eur Urol. 2022;81(Supplement 1):S1569.
Alharbi A, Khobrani A, Noor A, Alghamdi W, Alotaibi A, Alnuhait M, et al. Risk of lichen Sclerosus and lichen planus in patients receiving immune checkpoint inhibitors. Int J Environ Res Public Health. 2022;20:580.
Fahy CMR, Torgerson RR, Davis MDP. Final diagnosis of 112 girls presenting with genital Mucocutaneous symptoms and signs: the Mayo Clinic experience. Pediatr Dermatol. 2017;34:e279–e280.
Raj G, Bell HK. A multi-centre audit on genital lichen sclerosus in the north West of England. J Eur Acad Dermatol Venereol. 2014;28:963–966.
van der Meijden WI, Boffa MJ, ter Harmsel B, Kirtschig G, Lewis F, Moyal-Barracco M, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022;36:952–972.
Sauder MB, Linzon-Smith J, Beecker J. Extragenital bullous lichen sclerosus. J Am Acad Dermatol. 2014;71:981–984.
Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol. 1980;3:271–279.
Shiver M, Papasakelariou C, Brown JA, Wirges M, Kincannon J. Extragenital bullous lichen sclerosus in a pediatric patient: a case report and literature review. Pediatr Dermatol. 2014;31:383–385.
Kreuter A, Gambichler T, Avermaete A, Happe M, Bacharach-Buhles M, Hoffmann K, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol. 2002;46:251–255.
Shah CT, Mandell JW, Kirzhner M. Lichen sclerosus of the eyelid. Cutis. 2020;106:E16–E17.
Kawakami Y, Oyama N, Hanami Y, Kimura T, Kishimoto K, Yamamoto T. A case of lichen sclerosus of the scalp associated with autoantibodies to extracellular matrix protein 1. Arch Dermatol. 2009;145:1458–1460.
Mercieca L, Collier NJ, Motta L, Singh M. A linear hypopigmented lesion on the forehead. Clin Exp Dermatol. 2019;44:664–666.
Kreuter A, Tigges C, Gaifullina R, Kirschke J, Altmeyer P, Gambichler T. Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus. Arch Dermatol. 2009;145:1303–1308.
Uthayakumar AK, Kravvas G, Bunker CB. Extragenital lichen sclerosus arising in tattooed skin. BMJ Case Rep. 2022;15:e246216.
Glaser KS, Glaser EN, Piliang M, Anthony J. Extragenital lichen sclerosus et atrophicus within a skin graft scar. JAAD Case Rep. 2018;4:938–940.
van Cranenburgh OD, Nijland SBW, Lindeboom R, de Korte J, de Rie MA, ter Stege JA, et al. Patients with lichen sclerosus experience moderate satisfaction with treatment and impairment of quality of life: results of a cross-sectional study. Br J Dermatol. 2017;176:1508–1515.
Van De Nieuwenhof HP, Meeuwis KA, Nieboer TE, Vergeer MC, Massuger LF, De Hullu JA. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol. 2010;31:279–284.
Vittrup G, Mørup L, Heilesen T, Jensen D, Westmark S, Melgaard D. Quality of life and sexuality in women with lichen sclerosus: a cross-sectional study. Clin Exp Dermatol. 2022;47:343–350.
Poindexter G, Morrell DS. Anogenital pruritus: lichen sclerosus in children. Pediatr Ann. 2007;36:785–791.
Schlosser BJ, Mirowski GW. Lichen sclerosus and lichen planus in women and girls. Clin Obstet Gynecol. 2015;58:125–142.
van der Avoort IA, Tiemes DE, van Rossum MM, van der Vleuten CJ, Massuger LF, de Hullu JA. Lichen sclerosus: treatment and follow-up at the departments of gynaecology and dermatology. J Low Genit Tract Dis. 2010;14:118–123.
Yesudian PD, Sugunendran H, Bates CM, O'Mahony C. Lichen sclerosus. Int J STD AIDS. 2005;16:465–473, test 74.
Ventegodt S. The holistic vulva clinic: an integrative approach to the treatment of genital, sexual and non-sexual pain and the other health problems related to the female gender. J Pain Manage. 2010;3:217–232.
Simpson RC, Cooper SM, Kirtschig G, Larsen S, Lawton S, McPhee M, et al. Future research priorities for lichen sclerosus – results of a James Lind Alliance priority setting partnership. Br J Dermatol. 2019;180:1236–1237.
Tran DA, Tan X, Macri CJ, Goldstein AT, Fu SW. Lichen sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci. 2019;15:1429–1439.
Corazza M, Schettini N, Zedde P, Borghi A. Vulvar lichen sclerosus from pathophysiology to therapeutic approaches: evidence and prospects. Biomedicine. 2021;9:950.
Bocheńska K, Smolińska E, Moskot M, Jakóbkiewicz-Banecka J, Gabig-Cimińska M. Models in the research process of psoriasis. Int J Mol Sci. 2017;18:2514.
Kim D, Kobayashi T, Nagao K. Research techniques made simple: mouse models of atopic dermatitis. J Invest Dermatol. 2019;139:984–990.e1.
Chattopadhyay S, Arnold JD, Malayil L, Hittle L, Mongodin EF, Marathe KS, et al. Potential role of the skin and gut microbiota in premenarchal vulvar lichen sclerosus: a pilot case-control study. PLoS One. 2021;16:e0245243.
Virgili A, Borghi A, Cazzaniga S, di Landro A, Naldi L, Minghetti S, et al. Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases. G Ital Dermatol Venereol. 2020;155:155–160.
Kumar KS, Morrel B, van Hees CLM, van der Toorn F, van Dorp W, Mendels EJ. Comparison of lichen sclerosus in boys and girls: a systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosis. Pediatr Dermatol. 2022;39:400–408.
Carlson BC, Hofer MD, Ballek N, Yang XJ, Meeks JJ, Gonzalez CM. Protein markers of malignant potential in penile and vulvar lichen sclerosus. J Urol. 2013;190:399–406.
Paolino G, Panetta C, Cota C, Muscardin L, Donati P, Di Carlo A. Lichen sclerosus and the risk of malignant progression: a case series of 159 patients. G Ital Dermatol Venereol. 2013;148:673–678.
Potapov AL, Sirotkina MA, Matveev LA, Dudenkova VV, Elagin VV, Kuznetsov SS, et al. Multiphoton microscopy assessment of the structure and variability changes of dermal connective tissue in vulvar lichen sclerosus: a pilot study. J Biophotonics. 2022;15:e202200036.
Tedesco M, Bellei B, Garelli V, Caputo S, Latini A, Giuliani M, et al. Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: new regenerative perspectives in genital lichen sclerosus. Dermatol Ther. 2020;33:e14277.
Zucchi A, Cai T, Cavallini G, D'Achille G, Pastore AL, Franco G, et al. Genital lichen sclerosus in male patients: a new treatment with polydeoxyribonucleotide. Urol Int. 2016;97:98–103.
Villalpando BK, Wyles SP, Schaefer LA, Bodiford KJ, Bruce AJ. Platelet-rich plasma for the treatment of lichen sclerosus. Plast Aesthet Res. 2021;8:63.
Tedesco M, Garelli V, Elia F, Sperati F, Morrone A, Migliano E. Efficacy of injecting hybrid cooperative complexes of hyaluronic acid for the treatment of vulvar lichen sclerosus: a preliminary study. J Cosmet Dermatol. 2022;35:e15338.
Bernhardt T, Semmler ML, Schäfer M, Bekeschus S, Emmert S, Boeckmann L. Plasma medicine: applications of cold atmospheric pressure plasma in dermatology. Oxidative Med Cell Longev. 2019;2019:3873928.
Polat G, Erni B, Navarini A, Kind A, Mueller SM. Three patients with chronic vulvar pruritus successfully treated with cold atmospheric pressure plasma. J Dtsch Dermatol Ges. 2021;19:1346–1349.
Simpson RC, Kirtschig G, Selk A, von Seitzberg S, Vittrup G, Bissonnette I, et al. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement. Br J Dermatol. 2023;188:628–635.
Erni B, Navarini AA, Huang D, Schoetzau A, Kind A, Mueller SM. Proposition of a severity scale for lichen sclerosus: the “clinical lichen Sclerosus score”. Dermatol Ther. 2021;34:e14773.
